Acura
Pharmaceuticals, Inc.(NASDAQ:ACUR) is a specialty company that manufactures products intending to address
medication abuse and misuse. ACUR has announced on 27th July that
Pfizer Inc. has notified the previous day of using its right to cease the
license to three development stage products that uses Acura’s AVERSION
technology and return those products to Acura. The termination is supposed to
be active within 12 months under Pfizer’s License Agreement.
Another product that is
using Acura’s AVERSION technology, named OXECTA tablets CII is being
commercialized by Pfizer. Pfizer has decided to retain its rights over OXECTA
as per its License Agreement.
President and Chief
Executive Officer of Acura Pharmaceuticals, Bob Jones has announced the
company’s decision to regain control over tamper-resistant opioid products as
it has trust in fighting extensive prescription opioid mistreatment. Jones also
said that the company is examining strategy of transiting the products back to
them. Acura is also thinking of partnering with substitute strategic partners
and working together with Pfizer to make this venture a success.
Acura Pharmaceuticals
Inc. is planning on reporting financial results for the second quarter of the
year followed by the close of financial markets today. The company is schedules
to host a conference call on Tuesday at 8:30 AM ET in which, it wishes to
discuss Pfizer’s return on products apart from quarterly results.
Anyone, who is
interested in participating in live conference call, can dial 913-981-5535
(International) or 800-967-0627 (US and Canada). It would take 5-10 minutes to
transfer the call. The passcode for a participant is 8419237. There will also
be a live audio webcast available through ‘Investors’ section of the website of
ACUR.
The conference call as
well as the webcast will be archived for two weeks. The replay of a telephone
conversation will be available 2 hours after the completion of a call. Anyone
can access the recorded telephonic conversations by dialing 719-457-0820
(International) or 888-203-1112 (US and Canada) on provision of the passcode
8419237.
No comments:
Post a Comment